NS-1209, (±)-

Investigational

Details

Stereochemistry	RACEMIC
Molecular Formula	C24H28N4O7S
Molecular Weight	516.567
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C)S(=O)(=O)C1=CC=C(C=C1)C2=C3CCN(C)CC3=C4NC(=O)\C(=N/OC(CCO)C(O)=O)C4=C2

InChI

InChIKey=CFJRSKULEDUDKL-UHFFFAOYSA-N

InChI=1S/C24H28N4O7S/c1-27(2)36(33,34)15-6-4-14(5-7-15)17-12-18-21(19-13-28(3)10-8-16(17)19)25-23(30)22(18)26-35-20(9-11-29)24(31)32/h4-7,12,20,29H,8-11,13H2,1-3H3,(H,31,32)(H,25,26,30)

HIDE SMILES / InChI

Approval Year

PubMed

Title	Date	PubMed
Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.	2004 Sep	15275824
Modifications of antiepileptic drugs for improved tolerability and efficacy.	2008 Feb 14	19787095

Patents

Name

Type

Language

NS-1209, (±)-

Common Name

English

NS-1209, (RS)-

Common Name

English

2-(((5-(4-((DIMETHYLAMINO)SULFONYL)PHENYL)-1,2,6,7,8,9-HEXAHYDRO-8-METHYL-2-OXO-3H-PYRROLO(3,2-H)ISOQUINOLIN-3-YLIDENE)AMINO)OXY)-4-HYDROXYBUTANOIC ACID

Systematic Name

English

SPD-502

Common Name

English

(RS)-NS-1209

Code

English

BUTANOIC ACID, 2-(((5-(4-((DIMETHYLAMINO)SULFONYL)PHENYL)-1,2,6,7,8,9-HEXAHYDRO-8-METHYL-2-OXO-3H-PYRROLO(3,2-H)ISOQUINOLIN-3-YLIDENE)AMINO)OXY)-4-HYDROXY-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID70948364